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Abstract
We demonstrate the application of mixture density networks (MDNs) in the context of automated radiation
therapy treatment planning. It is shown that an MDN can produce good predictions of dose distributions as
well as reflect uncertain decision making associated with inherently conflicting clinical tradeoffs, in contrast
to deterministic methods previously investigated in literature. A two-component Gaussian MDN is trained
on a set of treatment plans for postoperative prostate patients with varying extents to which rectum dose
sparing was prioritized over target coverage. Examination on a test set of patients shows that the predicted
modes follow their respective ground truths well both spatially and in terms of their dose–volume histograms.
A special dose mimicking method based on the MDN output is used to produce deliverable plans and thereby
showcase the usability of voxel-wise predictive densities. Thus, this type of MDN may serve to support
clinicians in managing clinical tradeoffs and has the potential to improve quality of plans produced by an
automated treatment planning pipeline.
Keywords: Mixture density networks, dose prediction, dose mimicking, knowledge-based
planning, deep learning, radiation therapy treatment planning
Introduction
Radiation therapy is a cornerstone treatment used as single or combined treatment for more
than 40 percent of cancer patients (Borras et al 2016). Previous and emerging innovations in
imaging and treatment techniques have contributed to a more accurate radiation administration
to the tumor while simultaneously sparing organs at risk. Despite these improvements, different
processes of the radiation therapy workflow are still susceptible for variations. Important sources
of uncertainty include heterogeneity in the delineation of regions of interest (ROIs) (Brouwer
et al 2012, Veen et al 2019) and differences in preferences associated with conflicting clinical
tradeoffs for a particular treatment site (Nelms et al 2012). In particular, the radiation therapy
treatment planning (RTTP) process requires interaction between dosimetrists, medical physicists
and radiation oncologists to find the best treatment plan for each patient. The creation of a
deliverable plan typically involves repeatedly solving a large-scale optimization problem with
iteratively updated parameters, which makes it a time-consuming and labor-intensive step (Craft
∗These authors contributed equally to this work.
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et al 2012). Moreover, the process is characterized by a user-variability both intra- and inter-
institutional due to subjectivity in the management of tradeoffs between planning objectives
and institution-specific guidelines (Nelms et al 2012). Therefore, efforts have been made to
develop methods that can automate the RTTP process to reduce the time required for human
intervention and the variation between dosimetrists/physicists to improve overall plan quality
and consistency.
In this context, knowledge-based planning (KBP) could remedy the differences coming from
subjectivity and has the potential to homogenize the RTTP process (Berry et al 2016). Ge and
Wu (2019) divide current methods in KBP in two categories: (1) case- and atlas-based methods
and statistical modeling and (2) machine learning (ML) methods. In the former category, a
reduced plan quality variation is achieved by seeking similar patients in a cohort of available ones,
and then leveraging the knowledge from the previous case to a new patient. In the latter type,
a model is trained on a set of previously treated patients, which is then used to predict some
dose-related quantity for a new patient that is of assistance when creating a deliverable plan.
Examples of such quantities are beam angles, dose–volume histograms (DVHs), voxel-wise dose
and mean region doses (Ge and Wu 2019). Voxel-wise dose prediction methods have been created
using a variety of ML-based approaches. D Nguyen et al (2019) validate that a neural network
(NN) of U-net type can be applied for voxel-wise dose prediction based on patient contours for
prostate intensity-modulated radiation therapy, and Campbell et al (2017) use an NN to predict
dose for pancreatic stereotactic body radiotherapy (SBRT). Further developments of NNs for
KBP have been achieved by Kearney et al (2018) and Shiraishi and Moore (2016), where a
fully convolutional three-dimensional NN is created for dose prediction in prostate SBRT. Also,
generative approaches have been investigated in Mahmood et al (2018), Murakami et al (2020)
and Babier et al (2020), where voxel-wise dose is predicted by generative adversarial networks
(GANs). Other works have used more classical ML algorithms, e.g. random forest–based methods
to predict voxel doses (McIntosh and Purdie 2016, McIntosh et al 2017) and the application of
flow and shape models for spine SBRT (Liu et al 2015).
Common for previous NN-based approaches is that a single dose per voxel is outputted by
the ML algorithm—the dose of the predicted optimal treatment plan for the patient. However,
for complex cases, inter-planner variations with KBP will remain (Kubo et al 2019). Hence,
an optimal prediction could consist of the dose distribution that best mimics the behavior of
previously seen data, while there is still a possibility to incorporate other preferences by steering
the ML algorithm during training. This type of KBP can remedy the variability brought by
subjectivity of a planner in the RTTP process. However, since a single dose value is predicted in
each voxel, it will not be able to reflect more than one specific protocol and preference in the
model. Consequently, if there are potentially conflicting tradeoffs inherent in the treatment site,
where one would possibly have different protocols or objectives in place (e.g. complex cases), no
such concerns can be reflected in the same ML model.
The present work is an extension of previous methods by incorporating meaningful variations
in the RTTP problem in the output of ML algorithm, in particular demonstrating the variability
caused by prioritizing different clinical tradeoffs. This is achieved by using a mixture density
network to predict a possibly multimodal probability density function of dose in each voxel. This
can add to KBP not only a more homogenized manner of RTTP, but also a way of automatically
grasping the viable treatments based on clinically relevant variability, which could be of use as a
decision support mechanism in clinical practice. Moreover, an integral part of automated RTTP
by use of ML is the optimization to create a deliverable plan from a predicted dose distribution
subject to physical delivery constraints, commonly referred to as dose mimicking (McIntosh et al
2017). While dose mimicking can be done in a range of manners, in this paper, we present the
idea of incorporating the predictive probability distributions into the objective function as an
application of the implied uncertainties. Among other applications, it is also possible to use the
voxel-wise probability densities to post-process the predicted dose distribution to have the desired
DVHs in different regions of interest (McIntosh et al 2017), which constitutes a comprehensive
way of articulating additional preferences. Hence, a multimodal voxel dose distribution can bring
efficiency and improvements to a range of RTTP applications.
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Methods and materials
Model setup
In order to reflect a range of possible predictions with an ML model, its output must comprise
more than a deterministic output, such as a single dose value per voxel. A more informative
output would instead be a probability distribution per voxel, reflecting the range of possible
outcomes of dose values and their respective likelihoods given the planning standards learned
from the training data. In figure 1, an example of such a probability distribution for a voxel in
the target area is depicted.
More formally, let {(xn, dn)}Nn=1 be the training set consisting of independent random variable
pairs of contoured images xn and corresponding dose distributions dn. Given this and the current
patient image x = (xv)v as a vector over voxels v, the task is to obtain for each v the probability
distribution of the associated dose dv, i.e.
p(dv | x, {(xn, dn)}Nn=1). (1)
Note that this is the marginal predictive distribution for one particular voxel v. Although one
could, in principle, try to model the joint predictive distribution p(d | x, {(xn, dn)}Nn=1), it is
sufficient for the purposes of this study to obtain a collection of marginal distributions over all
voxels in the patient volume.
Figure 1. Visualization of a probability distribution of dose versus a deterministic dose for a
voxel in the target area.
Mixture density networks
As mentioned in the introduction, deep learning has been applied to the problem of voxel-wise
deterministic dose prediction, e.g. using U-nets. A novel idea is to extend the method presented
in D Nguyen et al (2019) around U-net prediction to instead output an inferred predictive
distribution pθ(dv | x), where θ denotes the network weights. While there are several approaches
to making NNs predict stochastic outputs, such as by sampling from a latent variable space
(Goodfellow et al 2014, Kingma and Welling 2013), we shall opt for a discriminative approach
where the marginal predictive distributions belong to some parametric family and where the
NN outputs are the corresponding parameters. The family of Gaussian mixture models has
the favorable property of being dense in the space of probability distributions (HD Nguyen
and McLachlan 2019)—in other words, it is a parametric family that can approximate any
distribution arbitrarily well. A one-dimensional Gaussian mixture model with C components is
a probability distribution with density function
C∑
c=1
αcN (· | µc, σ2c ), (2)
where N (· | µc, σ2c ) is the density function of the normal distribution with mean µc and variance
σ2c and where the class probabilities {αc}Cc=1 are nonnegative and sum to unity.
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Thus, a C-component Gaussian mixture model requires 3C parameters (alternatively, 3C − 1,
as one is implicit from the constraint that class probabilities sum to unity), which will be
outputted by the NN. Such an NN is known as a mixture density network (Bishop 1994). More
precisely, three functions αθ, µθ and σ2θ will be trained in the network, derived from the network
weights θ. αθ maps each input image x = (xv)v to a matrix with C rows, where the output
αθ(x)c in row c is the vector of the corresponding class probabilities (and similarly for µθ and
σ2θ). The inferred voxel-wise predictive likelihood can thus be written as
pθ(dv | x) =
C∑
c=1
αθ(x)vc N
(
dv | µθ(x)vc , σ2θ(x)vc
)
. (3)
This type of model is able to reflect any number of inherent distributional components.
Consider a dose inference problem where one knows there is a tradeoff prevalent in the data
stemming from two potential treatment protocols T1, T2. An MDN with two components can
reflect this behavior by predicting µ1, µ2 to match the average behavior of each protocol, and σ1,
σ2 to reflect the internal uncertainty of each prediction. In figure 2, one can see a visualization of
how such a predictive density could be in a voxel where this twofold dose preference is present.
4000 4500 5000 5500 6000 6500 7000
Dose [cGy]
0
Pr
ob
ab
ilit
y 
de
ns
ity
Mixture
Protocols
Figure 2. Visualization of how a probability distribution of dose could look like in a voxel,
where there are two protocols prescribing different amount of dose to the area. The distribution
is a mixture of the two distributions coming from each protocol.
Data
In order to carry out experiments demonstrating the sought variability for a site, a pertinent
clinical tradeoff is needed as a basis for the work. Studies have focused on analyzing the
radiobiological effect of restricting the dose to the rectum for prostate patients, possibly at the
cost of sacrificing target coverage, which is a clinical tradeoff that is central in prostate RTTP
(Mavroidis et al 2017). In this work we will use the dose variation in the rectum area to study
the ML method’s capability to identify and mimic these tradeoffs in its prediction.
The data used in this work originates from Iridium Cancer Network (Antwerp, Belgium) and
consists of prostate cancer patients having undergone a prostatectomy prior to radiation therapy.
The dataset contains both patients with and without pelvic nodes included in target volume.
All organs were contoured according to the RTOG (Gay et al 2012) and ACROP (Salembier
et al 2018) guidelines. Patients were treated in 35 fractions with a prescribed dose of 56 Gy to
the seminal vesicles and eventually also to the pelvic nodes. The prostate bed was treated with
a simultaneous integrated boost of 70 Gy. All plans were delivered using two 360◦ volumetric
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modulated arc therapy (VMAT) beams. The clinical goals used during the planning process are
summarized in table 1.
Table 1. Vital clinical goals in the Iridium postoperative prostate protocol.
Region Volume [%] Dose [Gy]
PTV Prostate 98 ≥ 66.5
0 ≤ 74.9
PTV Seminal Vesicles 98 ≥ 53.2
Rectum 10 ≤ 65
5 ≤ 70
Bladder 10 ≤ 70
In this work, the training data consisted of a pair P1, P2 of treatment plans created for each
patient, where P2 has a dose distribution that spares the rectum to a higher extent than P1, in
general at the cost of sacrificing target coverage. In figure 3, one can see the dose distributions for
each such plan in a transverse cross section for a representative patient. The training data was
generated by application of an ML-based dose prediction and dose mimicking optimization using
RayStation 9A (RaySearch Laboratories, Stockholm, Sweden). The ML algorithm used to predict
the doses was trained on approximately 100 clinical plans and is based on the method provided
in McIntosh and Purdie (2016). The model used to create the training data was configured to
predict one plan P1 that prioritizes target coverage and another plan P2 that prioritizes sparing
of the rectum area. By applying this planning process for 16 patients from the Iridium dataset,
32 plans were created for the training dataset. The objective of using this dual input of plans for
each patient is that one can easily validate that this twofold dose preference in the rectum is
reflected in new MDN predictions. Rather than creating two clinically acceptable plans, P1 and
P2 just reflect two different planning protocols.
Figure 3. Example of doses used for training. The slice of dose to the left represents the target
coverage plan P1 and the right one the the spare rectum plan P2. The slices are from the same
patient and position on the longitudinal axis.
Implementation
The architecture of the neural network used in this work is a U-net (Ronneberger et al 2015).
U-nets are convolutional neural networks with dimension 128× 176 in both the input and output
layers, and possibly differing number of channels. For this study, we restrict our attention to
predicting dose in each transversal slice separately. As mentioned in the introduction, this type
of approach has been used for dose prediction successfully.
The input to the U-net could be a CT image with radiodensities and/or contoured ROIs. As
the latter alone has proven to be successful for the task, the network built for this work uses only
the ROI contours. The ROIs included are the External (the full body), PTV Prostate, PTV
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Seminal Vesicles, Rectum and Bladder. Hence, the input layer has five channels. The simplest
representation of the input ROIs are their binary encoding in the three-dimensional patient
volume, but since the prediction is based on transversal slices, proximity information of ROIs in
the craniocaudal direction would be lost. To account for this, a Euclidean distance transform is
applied to each ROI before separating the slices. That is, letting dEucl denote spatial distance,
the Euclidean distance transform TR with respect to a ROI R is a map from voxel to scalar,
given by
T (v) = min
v′∈R
dEucl(v, v′). (4)
In this work, and augmented version TˆR given by TˆR(v) = TR(v) − TRc(v), Rc denoting the
complement of R, is used to provide more local information when v ∈ R.
The output of the network is the distributional parameters in each voxel. In this work
attention is restricted to a bimodal Gaussian mixture, as the tradeoff we are focusing on comes
from two protocols P1, P2, i.e. C = 2. Thus, the output should have 3C = 6 channels. U-nets
have a contractive phase, followed by an expansive phase. During the contractive phase, the
image is successively downsampled using max-pooling. As the image shrinks, the number of
channels is simultaneously increased, which allows higher-level contextual information to be
represented. In the expansive phase, this is propagated up to the original resolution using
upsampling. Fine-grained information may be lost in the contractive part of the network.
Therefore, there are “skip connections” between the phases where detailed input from each step
in the downsampling is propagated to the upsamling part. For an illustration of the complete
architecture used, see figure 4.
Figure 4. Architecture of the U-net. Each bar represents a layer and the number on top of each
the number of channels.
A loss function that reflects the NN’s performance in this setting is the negative log-likelihood
of the data, which measures how probabilistically congruent our data is to the proposed dis-
tributions in each voxel. However, since voxels are not equally critical to the plan, we use
a loss function where local negative log-likelihoods − log pθ(dv | x), known from Equation 3,
have weights wv reflecting their relative importance. Additionally, to avoid mode collapse—i.e.,
making sure that the class probabilities do not vanish—we use a regularization penalty
bv(θ;x) = max{(α0 − αθ(x)vc )+}Cc=1 (5)
for each voxel, α0 being some threshold constant. The loss function L(θ;x, d) associated with
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the pair (x, d), which in this case are both slice-specific, can thus be written as
L(θ;x, d) =
∑
v
(−wv log p(dv | x) + λbv(θ;x)) , (6)
where λ is some scaling factor. The constants {wv}v, α0 and λ can be seen as hyperparameters
of the model and have been configured by hand. For our computational study, we used
wv =

0.05 if v is in air,
5 if v is exclusively in PTV or rectum,
10 if v is in PTV and rectum,
1 otherwise,
α0 = 0.2, λ = 20. (7)
Experiments are implemented using TensorFlow 2.2 and TensorFlow Probability 0.10. The
model is trained using Adam (Kingma and Ba 2014) with standard parameters. The final
model is selected as the one with the lowest validation loss during training and evaluated on an
untouched holdout data set. A train/validation/holdout ratio of 50/25/25 is used—specifically,
there are 16 patients in the training set, 8 in the validation set and 9 in the holdout set.
Dose mimicking
To demonstrate the usability of predictive probability distributions such as those outputted by
the MDN, we use a specially developed dose mimicking method to create deliverable treatment
plans according to the predictions. Since the mixtures comprise two components, two plans may
be created for each patient—one where the dose should mimic µ1 and one for µ2. For each v,
let F v be the cumulative distribution function associated with one chosen mixture component
of the predictive density p(dv | x), and let tv be such that tv = 0 if the dose to voxel v is to be
minimized and tv = 1 otherwise. In particular, when v belongs to both the PTV and the rectum,
we use tv = 1 if mimicking µ1 and tv = 0 if mimicking µ2. The objective function ψSpat on the
spatial dose distribution is written as sum of cross-entropy losses over all voxels in the patient
volume—that is,
ψSpat(d) = −
∑
v
rv
(
tv logF v(dv) + (1− tv) log(1− F v(dv))
)
, (8)
where rv is the voxel volume of v relative to the whole patient volume, satisfying
∑
v r
v = 1. To
ensure homogeneity in target doses and, in general, that the deliverable dose follows the DVHs
of the prediction closely, we add for each ROI R in the model a so called reference-DVH function
ψDVH,R with µ1 or µ2 as reference dose. Their definitions are described in detail in Fredriksson
(2012).
The optimizations were performed using direct machine parameter optimization with the
same beam settings as used in the original data. Let η denote the optimization variables with
feasible set E , where the total dose d is determined by some dose deposition mapping d = d(η)
according to, for example, Unkelbach et al (2015). The optimization problem may then be
written as
minimize
η∈E
wSpatψSpat(d(η)) +
∑
R
wDVH,RψDVH,R(d(η)), (9)
wSpat, wDVH being weights. For our computational study, we used wSpat = 10−4 and wDVH,R =
102 for organs at risk and wDVH,R = 103 for targets. The problem above was solved using
RayStation’s native sequential quadratic programming solver, and final doses were calculated
using a collapsed cone algorithm.
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Results
The MDN trained for 100 epochs, although after around 50 epochs the final model is typically
selected due to incipient overfitting. After training the network, its performance is assessed
through some qualitative inspections. As it is difficult in general to evaluate fitted predictive
distributions, the focus of this section is to provide some key visualizations of the model behavior
compared to ground truth counterpart.
First of all, one would like to see that the two data modes P1, P2 have indeed been separated.
Thus, a central transversal slice from a patient is firstly studied in figure 5, where the two
modes µ1 and µ2 are plotted. We also show the predicted standard deviation in each mode. For
reference, the ground truth dose for each data mode P1 and P2 is plotted.
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Figure 5. In left column: expected dose value µ1, µ2 [cGy] in a transversal slice from a
validation patient. In middle column: dose values in ground truth plans in [cGy] and
corresponding slice. In right column: parameters σ1, σ2 in [cGy] the same slice.
Examining the modes in figure 5, one sees that µ2 predicts the dimple present in P2, while µ1 has
the the higher target coverage characteristic of P1. Another way to clearly demonstrate that the
modes have separated is to plot the difference µ1 − µ2. In figure 6, one can see that the modes
are indeed separated in and around the rectum, while differences in other regions are smaller.
1 2
2000
1000
0
1000
2000
3000
4000
Figure 6. Dose difference between predicted means µ1, µ2.
In order to validate the network across the holdout set (as opposed to only the one patient in
figures 5, 6), we compare the distribution of dose values in equivalent locations for the patients to
the predicted counterparts. The points are drawn along a line in the anterior–posterior direction
passing through the center of mass of the rectum in the slice (figures 5, 6) and corresponding
slices through the holdout set. Samples are drawn from the two predicted components for each
patient and compared to the distribution in P1 and P2 using boxplots in figure 7. Five samples
are drawn for each patient in order to stabilize the empirical distribution and thus the box
positions.
One sees that µ1 manages to follow P1 well through the drop-off, although a slight discrepancy
can be made out when the offset exceeds 10mm, while µ2 follows P2 well.
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Figure 7. Distributions of dose values in the predicted mixture components versus the ground
truth in the holdout set, on points along a path through the rectum shown to the right. The
point at the mass center of the rectum corresponds to an offset of 0. The black small markings
show outliers.
Illustrations such as figures 5, 6 and 7 give a detailed assessment of the model in the most
critical area of the patient body, where the PTV is the largest and has the most overlap with
the rectum. As such, however, they focus on one single representative patient and the dose
distribution in a vital slice at a time. A way of examining the behavior throughout the patient
body rather than in just one slice, and also for a larger test set, is by comparing differential or
cumulative DVHs. In particular, one would like to see that the DVHs of µ1 and µ2 agree with
P1 and P2, respectively. Using kernel density estimates, the differential DVHs for the rectum
area for a cohort of test patients are shown in figure 8.
In figure 8, it is apparent that the two plans P1 and P2 have created two separate and
characteristic distributions in the rectum area. Furthermore, it can be seen that that the
predictive modes µ1 or µ2 have successfully recreated this behavior, thus reflecting the clinical
tradeoff in the region. The corresponding cumulative DVHs are also examined for ROIs included
in the model. In figure 9, the averages of the DVHs of the predictive modes µ1, µ2 throughout
the holdout set are shown alongside the ground truth counterparts P1, P2, respectively. The
predicted modes follow the ground truth well for the risk organs and the prostate, essentially
capturing the distinct behaviors of P1, P2. However, the dose to the seminal vesicles is somewhat
overestimated, also causing the predicted DVH of the external ROI to deviate slightly. This is
not entirely unexpected, considering the fact that the MDN is not trained to necessarily produce
predictive means close to the ground truth in terms of DVH. Apart from the seminal vesicles,
the overall plan consistency is kept by the MDN and not only the variations in the rectum are
reflected in the predictions.
Finally, to demonstrate that the proposed dose mimicking method can successfully utilize the
predictive distributions outputted by the MDN, we create two deliverable plans for a patient
in the holdout set mimicking, respectively, µ1 and µ2. Spatial dose and DVH comparisons are
shown in figures 10 and 11. For both cases, one can see that the spatial dose distributions follow
the respective predictive modes well, although being slightly less conformal. This is most likely
due to the predictions being overly optimistic in the rate by which dose falls off around the target
area. One can also see that the DVHs of the mimicked plans followed closely or were in some
cases even better than those predicted. While these results show the merits of a probabilistic
dose mimicking method, in a clinical setting, one would likely need to further post-process the
obtained plans before approval and delivery.
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Figure 8. Differental DVHs for the rectum in eight patients. The ground truths P1, P2 are
shown next to the predictive modes µ1, µ2.
0 1000 2000 3000 4000 5000 6000 7000 8000
Dose [cGy]
0.0
0.2
0.4
0.6
0.8
1.0
Re
la
tiv
e 
vo
lu
m
e
P1
P2
μ1
μ2
External
PTV Prostate
Rectum
Bladder
PTV Seminal Vesicles
Figure 9. Average cumulative DVH for the patients in the test set for ground truths P1, P2 and
predictive modes µ1, µ2.
Discussion
In this work, we have demonstrated the application of MDNs for probabilistic dose prediction,
which has certain advantages when used in an automated RTTP pipeline. We showed that this
type of NN can produce predictive probability distributions capturing the uncertain nature of
decision making associated with conflicting clinical tradeoffs. This was exemplified on a dataset
comprising postoperative prostate cancer patients in which two plans had been created for each
patient—one prioritizing target coverage and one prioritizing rectum sparing. Visual inspection
across the holdout set showed that the predicted modes followed the respective ground truths
well, and the predictive uncertainties were assured to be reasonable by examining the distribution
of ground truth dose values around different locations. This has the potential to bring together
a comprehensive overview of viable plan alternatives for a given patient, which can not only
act as a time-saving tool but also facilitate easier decision making during the RTTP process.
In particular, as an example of the usability of a probabilistic prediction, we used a specially
developed dose mimicking method to create deliverable plans for each of the predicted mixture
components.
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Figure 10. Comparison of predicted and mimicked spatial dose distributions in a transversal
slice for the cases of mimicking µ1 and µ2, respectively.
While most of previous work has focused on the prediction of a single dose value per
voxel, one can, for example, argue that an empirical distribution can be obtained by sampling
from generative models, e.g. GANs (Babier et al 2020, Mahmood et al 2018) or variational
autoencoders (Kingma and Welling 2013). However, using such approaches, there is no clear
way of obtaining the conditional densities p(dv | x) we sought to model in this paper. Also, in
the atlas-based method by McIntosh and Purdie (2016), a set of dose propositions are predicted
for each voxel by the voting of weak learners, which may be seen as a sample from p(dv | x).
The actual density may then be estimated by e.g. kernel density estimation, but compared to
MDNs, this approach requires many more parameters to form the densities, and it is moreover
not obvious how one would go about separating the modes as was done for our dose mimicking.
In these regards, it is concluded that MDNs present advantages over existing methods.
Examples of future work include studying disjoint sets of patients having different treatment
protocols and using more realistic data from actually administered clinical plans. It would
also be of interest to investigate data with other types of tradeoffs—for example, plans with
or without a boost volume inside the PTV, or plans with intentional NTCP variations such
as for head-and-neck, where saliva glands are spared to different extent in various protocols.
Depending on the training data, one could look at other types of MDNs, e.g. an NN with more
Gaussian mixture components, should the tradeoffs need more modes to be described. Future
work could also focus on implementation parts, such making the MDN a three-dimensional
NN instead of predicting per slice, and various ways to counteract overfitting or stabilizing the
training process for this high-dimensional problem that can be prone to mode collapse. Another
possible future investigation would be to use the knowledge captured by the MDN in multicriteria
optimization, which is a natural application of the multimodal predictive distributions where
clinically conflicting tradeoffs may be reflected.
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Figure 11. Comparison of predicted and mimicked DVHs for the cases of mimicking µ1 and µ2,
respectively.
Conclusion
The application of MDNs to dose prediction is a promising method toward automation of the
RTTP process. In this work, we have shown that an MDN can predict dose distributions well
and, as opposed to deterministic methods, capture different decision alternatives associated with
conflicting clinical tradeoffs. In particular, a two-component Gaussian MDN was trained on a
dataset of treatment plans for prostate cancer patients with two distinguished degrees of priority
of rectum dose sparing over target coverage. Evaluation on the holdout set showed that the
produced probability distributions had predictive means following closely the respective ground
truths in terms of spatial dose and partly in DVH, as well as reasonable predictive variances.
Moreover, deliverable plans were created using a specially developed dose mimicking procedure,
exemplifying the usability of such probabilistic information. In conclusion, the proposed method
may serve to assist clinicians in decision making and improve the quality of treatment plans
produced by an automated RTTP pipeline.
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